ArticleInternational journal of reproductive biomedicine2026
Pemphigoid gestationis: A case report on maternal and neonatal outcomes.
Article in International journal of reproductive biomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pemphigoid gestationis is a rare skin disease of pregnancy. It can be misdiagnosed due to its many similarities to other dermatoses of pregnancy, and failure to diagnose can be associated with adverse maternal and fetal outcomes. Case Presentation: We describe a 19-yr-old Iranian primiparous woman who admitted to the Imam Dermatology Clinic, Ahvaz, Iran, at 35 wk of gestation with extensive blistering lesions. Definite diagnosis was confirmed by skin biopsy, and systemic and topical therapies were initiated. The newborn was delivered by cesarean section at 38 wk of gestation due to ruptured membranes and meconium-stained amniotic fluid. The infant appeared healthy, with no skin manifestations. The disease flared after postpartum corticosteroid tapering, requiring re-escalation of therapy. At 6 wk postpartum, hyperpigmentation was fading without scarring, and pruritus was limited to new lesions. Conclusion: Timely diagnosis and multidisciplinary management of pemphigoid gestationis can prevent adverse maternal and fetal outcomes. The observed meconium passage at 38 wk warrants further investigation into potential fetal effects of this condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.